149 related articles for article (PubMed ID: 34839098)
1. Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis.
Goh XX; Tang PY; Tee SF
Asian J Psychiatr; 2022 Jan; 67():102932. PubMed ID: 34839098
[TBL] [Abstract][Full Text] [Related]
2. Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis.
Goh XX; Tang PY; Tee SF
Psychiatry Res; 2022 Mar; 309():114429. PubMed ID: 35150976
[TBL] [Abstract][Full Text] [Related]
3. Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.
Bai ZL; Li XS; Chen GY; Du Y; Wei ZX; Chen X; Zheng GE; Deng W; Cheng Y
J Mol Neurosci; 2018 Nov; 66(3):428-436. PubMed ID: 30298298
[TBL] [Abstract][Full Text] [Related]
4. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics.
Khan MM; Evans DR; Gunna V; Scheffer RE; Parikh VV; Mahadik SP
Schizophr Res; 2002 Nov; 58(1):1-10. PubMed ID: 12363384
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis.
Yang M; Wang C; Zhao G; Kong D; Liu L; Yuan S; Chen W; Feng C; Li Z
Curr Neuropharmacol; 2023; 21(2):340-352. PubMed ID: 35794775
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with schizophrenia.
Vidović B; Milovanović S; Dorđević B; Kotur-Stevuljević J; Stefanović A; Ivanišević J; Miljković M; Spasić S; Stojanović D; Pantović M
Psychiatr Danub; 2014 Sep; 26(3):205-13. PubMed ID: 25191766
[TBL] [Abstract][Full Text] [Related]
8. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.
Lesh TA; Tanase C; Geib BR; Niendam TA; Yoon JH; Minzenberg MJ; Ragland JD; Solomon M; Carter CS
JAMA Psychiatry; 2015 Mar; 72(3):226-34. PubMed ID: 25588194
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation in patients with schizophrenia.
Dietrich-Muszalska A; Kontek B
Psychiatry Clin Neurosci; 2010 Oct; 64(5):469-75. PubMed ID: 20923426
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine.
Gama CS; Salvador M; Andreazza AC; Kapczinski F; Silva Belmonte-de-Abreu P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):512-5. PubMed ID: 16426720
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma.
Dietrich-Muszalska A; Kolińska-Łukaszuk J
Psychiatry Clin Neurosci; 2018 May; 72(5):329-336. PubMed ID: 29280533
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics.
Dakhale G; Khanzode S; Khanzode S; Saoji A; Khobragade L; Turankar A
Neuropsychobiology; 2004; 49(4):205-9. PubMed ID: 15154399
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics do not reverse prepulse inhibition deficits in acutely psychotic schizophrenia.
Xue YY; Wang HN; Xue F; Tan QR
J Int Med Res; 2012; 40(4):1467-75. PubMed ID: 22971498
[TBL] [Abstract][Full Text] [Related]
14. Free radicals, antioxidant defense systems, and schizophrenia.
Wu JQ; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():200-6. PubMed ID: 23470289
[TBL] [Abstract][Full Text] [Related]
15. Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects.
Choi KH; Higgs BW; Weis S; Song J; Llenos IC; Dulay JR; Yolken RH; Webster MJ
BMC Psychiatry; 2009 Sep; 9():57. PubMed ID: 19758435
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of oxidative stress markers in schizophrenia.
Zhang M; Zhao Z; He L; Wan C
Sci China Life Sci; 2010 Jan; 53(1):112-124. PubMed ID: 20596963
[TBL] [Abstract][Full Text] [Related]
17. Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia.
Mujica-Parodi LR; Yeragani V; Malaspina D
Neuropsychobiology; 2005; 51(1):10-5. PubMed ID: 15627808
[TBL] [Abstract][Full Text] [Related]
18. Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps.
Zhang B; Deng L; Wu H; Lu X; Peng L; Wu R; Guo W; Chen J; Li L; Zhao J
Schizophr Res; 2016 Oct; 176(2-3):259-263. PubMed ID: 27377977
[TBL] [Abstract][Full Text] [Related]
19. Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients.
Mackeprang T; Kristiansen KT; Glenthoj BY
Biol Psychiatry; 2002 Nov; 52(9):863-73. PubMed ID: 12399139
[TBL] [Abstract][Full Text] [Related]
20. Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.
Sarandol A; Kirli S; Akkaya C; Altin A; Demirci M; Sarandol E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1164-9. PubMed ID: 17459548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
